Literature DB >> 11745822

Expression of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in liver tumor lesions of rat models.

H Ohkame1, H Masuda, Y Ishii, Y Kanai.   

Abstract

BACKGROUND AND OBJECTIVES: It has been said that amino acid transporters play an important role in supplying nutrition to cells and for cell proliferation. In this study, we examined whether LAT1 and 4F2hc are closely related to tumor growth.
METHODS: Rat colon cancer cells (RCN-9) were injected into the spleen of 12 male rats (inbred F344/DuCrj). In each rat, liver samples including tumor lesions were immunostained with anti-LAT1 and anti-4F2hc antibodies. The staining area of LAT1 and 4F2hc tumor lesions was calculated by computer analysis.
RESULTS: Sixty-eight tumor nodules were observed in 12 livers. Out of the 68 tumor nodules, 36 nodules (52.9%) indicated a positive staining of LAT1 and 32 (47.1%) had a negative staining of LAT1. However, the LAT1 expression was scarcely detected in non-tumor areas. In terms of the 4F2hc expression, there were 56 nodules (82.4%) with 4F2hc positive and 12 (17.6) with 4F2hc negative. In addition, the expression of 4F2hc in non-tumor areas was almost the same as the expression of 4F2hc in tumor lesions. The average tumor size of the group with LAT1 positive and 4F2hc positive (n = 31) was 0.845 +/- 0.232 mm(2), which was significantly larger than that of the group with LAT1 negative and 4F2hc negative group (n = 7) (0.090 +/- 0.028 mm(2)) or the group with LAT1 positive and 4F2hc negative (n = 5) (0.097 +/- 0.025 mm(2)), respectively (P = 0.0017, P = 0.007).
CONCLUSION: LAT1 was related to tumor growth. We think that LAT1 can possibly enhance its ability to promote tumor growth in cooperation with 4F2hc. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745822     DOI: 10.1002/jso.1165

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  19 in total

1.  Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice.

Authors:  Bo Xiao; Hamed Laroui; Emilie Viennois; Saravanan Ayyadurai; Moiz A Charania; Yuchen Zhang; Zhan Zhang; Mark T Baker; Benyue Zhang; Andrew T Gewirtz; Didier Merlin
Journal:  Gastroenterology       Date:  2014-02-04       Impact factor: 22.682

2.  LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lung.

Authors:  Kuniaki Nakanishi; Hirotaka Matsuo; Yoshikatsu Kanai; Hitoshi Endou; Sadayuki Hiroi; Susumu Tominaga; Makio Mukai; Eiji Ikeda; Yuichi Ozeki; Shinsuke Aida; Toshiaki Kawai
Journal:  Virchows Arch       Date:  2005-09-21       Impact factor: 4.064

Review 3.  L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia.

Authors:  Qian Wang; Jeff Holst
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

4.  Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancer.

Authors:  Kyoichi Kaira; Noboru Oriuchi; Hisao Imai; Kimihiro Shimizu; Noriko Yanagitani; Noriaki Sunaga; Takeshi Hisada; Osamu Kawashima; Yosuke Kamide; Tamotsu Ishizuka; Yoshikatsu Kanai; Takashi Nakajima; Masatomo Mori
Journal:  Exp Ther Med       Date:  2010-07-20       Impact factor: 2.447

5.  Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells.

Authors:  Barbara Stöber; Ursula Tanase; Michael Herz; Christof Seidl; Markus Schwaiger; Reingard Senekowitsch-Schmidtke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-08       Impact factor: 9.236

Review 6.  Intestinal epithelial CD98: an oligomeric and multifunctional protein.

Authors:  Yutao Yan; Sona Vasudevan; Hang Thi Thu Nguyen; Didier Merlin
Journal:  Biochim Biophys Acta       Date:  2008-06-24

7.  MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation.

Authors:  Hang Thi Thu Nguyen; Guillaume Dalmasso; Yutao Yan; Hamed Laroui; Stephanie Dahan; Lloyd Mayer; Shanthi V Sitaraman; Didier Merlin
Journal:  J Biol Chem       Date:  2009-11-04       Impact factor: 5.157

Review 8.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  L-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett's adenocarcinoma.

Authors:  Jules Lin; Duna A Raoof; Dafydd G Thomas; Joel K Greenson; Thomas J Giordano; Gregory S Robinson; Maureen J Bourner; Christopher T Bauer; Mark B Orringer; David G Beer
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

10.  Significance of system L amino acid transporter 1 (LAT-1) and 4F2 heavy chain (4F2hc) expression in human developing intestines.

Authors:  Chikara Ohno; Yohko Nakanishi; Taku Honma; Akihiro Henmi; Masahiko Sugitani; Yoshikatsu Kanai; Norimichi Nemoto
Journal:  Acta Histochem Cytochem       Date:  2009-05-29       Impact factor: 1.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.